Literature DB >> 26875518

Serum γ-glutamyltransferase and Mortality due to Cardiovascular Disease in Japanese Men and Women.

Yuanying Li1, Hiroyasu Iso, Renzhe Cui, Yoshitaka Murakami, Hiroshi Yatsuya, Katsuyuki Miura, Shin-Ya Nagasawa, Hirotsugu Ueshima, Tomonori Okamura.   

Abstract

AIM: Whether the association between serum γ-glutamyltransferase (γ-GTP) levels and total cardiovascular disease (CVD) mortality is independent of alcohol drinking in East Asian populations is not well known. We conducted a pooled analysis of Japanese men and women that enabled an analysis restricted to never-drinkers.
METHODS: A total of 15,987 men and 25,053 women aged 40-79 years, pooled from seven cohort studies throughout Japan, were followed-up to examine sex-specific relationship between serum γ-GTP levels and total CVD mortality. Cox regression model was used that was adjusted for age, smoking status, body mass index, and systolic blood pressure and serum triglyceride, total cholesterol, aspartate aminotransferase, and alanine aminotransferase levels.
RESULTS: During an average follow-up of 8.7 years, we documented 361 and 340 deaths from total CVD, 146 and 168 from stroke, and 101 and 53 from coronary heart disease (CHD) for men and women, respectively. Among the never-drinkers, hazard ratios (HRs) for mortality for one standard deviation of log-γ-GTP for men were 1.89 (1.00-3.58) for stroke, 1.04 (0.57-1.90) for CHD, and 1.43 (1.04-1.96) for total CVD. For women, HRs were 1.28 (1.06-1.54), 1.81 (1.34-2.44), and 1.30 (1.14-1.49), respectively.
CONCLUSION: γ-GTP may be a risk factor for total CVD mortality independent of alcohol drinking status in Japanese men and women.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26875518     DOI: 10.5551/jat.32698

Source DB:  PubMed          Journal:  J Atheroscler Thromb        ISSN: 1340-3478            Impact factor:   4.928


  6 in total

1.  Serum gamma-glutamyltransferase is not associated with subclinical atherosclerosis in patients with type 2 diabetes.

Authors:  Hye Eun Yoon; Eun Young Mo; Seok Joon Shin; Sung Dae Moon; Je Ho Han; Eun Sook Kim
Journal:  Cardiovasc Diabetol       Date:  2016-08-05       Impact factor: 9.951

2.  Gamma-glutamyltransferase and risk of cardiovascular mortality: A dose-response meta-analysis of prospective cohort studies.

Authors:  Junna Wang; Dandan Zhang; Rongzhong Huang; Xingsheng Li; Wenxiang Huang
Journal:  PLoS One       Date:  2017-02-23       Impact factor: 3.240

3.  Implication of liver enzymes on incident cardiovascular diseases and mortality: A nationwide population-based cohort study.

Authors:  Kyung Mook Choi; Kyungdo Han; Sanghyun Park; Hye Soo Chung; Nam Hoon Kim; Hye Jin Yoo; Ji-A Seo; Sin Gon Kim; Nan Hee Kim; Sei Hyun Baik; Yong Gyu Park; Seon Mee Kim
Journal:  Sci Rep       Date:  2018-02-28       Impact factor: 4.379

4.  Serum Gamma-Glutamyltransferase Levels are Associated with Cardiovascular Risk Factors in China: A Nationwide Population-Based Study.

Authors:  Dan-Dan Li; Tao Xu; Xin-Qi Cheng; Wei Wu; Yi-Cong Ye; Xiu-Zhi Guo; Qian Cheng; Qian Liu; Li Liu; Guang-Jin Zhu; Jie Wu; Ling Qiu
Journal:  Sci Rep       Date:  2018-11-08       Impact factor: 4.379

5.  Features of the metabolic syndrome and subclinical atherosclerosis in patients with cerebrotendinous xanthomatosis: An augmented risk for premature cardiovascular disease.

Authors:  H Cohen; S Hassin-Baer; A Shaish
Journal:  Front Genet       Date:  2022-09-27       Impact factor: 4.772

6.  Prognostic Value of Gamma-Glutamyltransferase in Male Patients With Idiopathic Pulmonary Arterial Hypertension.

Authors:  Gang-Hua Lu; Su-Gang Gong; Chao Li; Qin-Hua Zhao; Rong Jiang; Ci-Jun Luo; Lan Wang; Rui Zhang
Journal:  Front Cardiovasc Med       Date:  2020-10-23
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.